CATHERINE MARINGER: Open Payments
NPI 1407519762 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 40 payments from 10 companies in 2025. Trend: 2023 $187 · 2024 $1,108 · 2025 $1,054
Food & beverage: $888Education: $166
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $257 |
| Regeneron Healthcare Solutions, Inc. | 4 | $193 |
| UCB, Inc. | 6 | $166 |
| Janssen Biotech, Inc. | 3 | $105 |
| ABBVIE INC. | 6 | $105 |
| GENZYME CORPORATION | 3 | $77 |
| Lilly USA, LLC | 4 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
| Organon LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, TREMFYA, SKYRIZI, AKLIEF, TALTZ, ILUMYA.
Industry payments across IN — which companies pay providers there.
